Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results

d, (8) receive required regulatory approvals, (9) successfully conduct clinical trials in a timely manner, (10) establish its competitive position for its products, (11) develop and commercialize products that are superior to existing or newly developed competitor products, (12) develop products without any defects, (13) have sufficient capital resources to fund its operations, (14) protect its intellectual property rights and patents, (15) implement its sales and marketing strategy, (16) successfully attract and retain collaborative partners, (17) successfully commercialize and gain market acceptance for its Keflex products, (18) successfully obtain sufficient manufactured quantities of its drug products at acceptable rates, and (19) retain its senior management and other personnel. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. MiddleBrook undertakes no obligation to update or revise the information in this announcement, whether as a result of new information, future events or circumstances or otherwise.




Three Months Ended Sept 30, Nine Months Ended Sept 30,

2007 2006 2007 2006

Product sales $3,144,532 $2,369,975 $7,598,127 $3,566,563

Costs and


Cost of product

sales 1,183,772 440,159 1,864,643 517,765

Research and

development 5,509,093 5,737,047 18,485,164 19,700,263

Selling, general

and administrative 6,475,742 6,069,529 20,473,947 13,001,312


expenses 13,168,607 12,246,735 40,823,754 33,219,340

Loss from


SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
(Date:12/21/2014)... (PRWEB) December 21, 2014’s new ... There is a total of 1,000 new designs in ... the coming spring 2015. , promises ... female shoppers with wardrobe essentials while many fashion trends ... problems, the customer service team at is ready ...
(Date:12/21/2014)... one of the best prom dresses online shops around ... its new collection of 2015 prom dresses, and announced ... prom dresses & other fashionable designs, up to 80 ... dress products and great customer services to its global ... best prom dresses online shops around the world by ...
(Date:12/21/2014)... 21, 2014 Serious Buyer, Andrew Hawley ... Jm Morrison and the Doors International Ballroom at the ... also be the only time that Morrison's mother would ... Nov. 25, 1967. According to Hawley, “This would be ... play the Alexandria Roller Rink earlier that year and ...
(Date:12/21/2014)... 2014 SCI explores disability ... and systemic barriers for disabled athletes with Aaron ... has a condition called juvenile macular degeneration, where he ... he adapted his athletic ambitions to his vision and ... triathlon to pioneer the way for other blind and ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 celebrates marijuana’s ... The only one of its kind, the site has ... local marijuana for 14 years running. It uniquely combines ... to make cannabis readily available to the masses. Assuring ... grasping the golden ring of public approval. , ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2
... for the smallest babies, studies show, , , WEDNESDAY, Oct. ... if they might help prevent serious complications and deaths ... results, studies show. , The studies -- one ... the effects of aggressive phototherapy -- found that neither ...
... management, discharge instructions not rated high in survey , , ... U.S. hospitals are not satisfied with their care, Harvard ... patients, experiences, many hospitals were found wanting in key ... fact, almost one-third of patients gave low ratings to ...
... 29 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... discuss third quarter 2008 financial,results and provide a general ... Eastern Time (2:00 p.m. Pacific Time). Financial results,for the ... earlier,that day., Interested parties may ...
... Uses Sophisticated Technology to Match Physicians with Hiring Organizations ... ... Aliso Viejo, California (PRWEB) October 29, 2008 -- ... , to provide physicians a simple solution to ...
... shopping spree, OAKLAND, Calif., Oct. 29 ... in scrubs, pay for a lot of,medications or ... an,incredibly expensive wardrobe., A new internet game ... Organizing Committee,, lets web users themselves ...
... the creation of over 2,000 housing opportunities ... ... elected officials,community leaders, and housing and support services professionals gathered,in Duluth ... of creating more than 2,000 housing,opportunities with support services for Minnesota ...
Cached Medicine News:Health News:Two Preemie Treatments May Not Help 2Health News:Two Preemie Treatments May Not Help 3Health News:U.S. Hospitals Lag in Patient Satisfaction 2Health News:U.S. Hospitals Lag in Patient Satisfaction 3Health Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 2Health Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 3Health News:The Neiman Marxist in the Presidential Race 2Health News:Minnesota Reaches Milestone in Goal to End Homelessness 2
(Date:12/19/2014)... , Dec. 18, 2014  RESMED INC. (NYSE: ... quarter of fiscal year 2015 results on Thursday, January 22, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:12/19/2014)... China separating membrane market has witnessed robust development ... years, albeit as a later starter. In 2012, the size ... approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. ... membrane market will continue its growth rate by around 20% ... will jump to roughly RMB25 billion. An integrated ...
(Date:12/17/2014)... N.Y. , Dec. 17, 2014  Northstar ... The Depository Trust Company (DTC) has made their ... Deposit Chill on the Company,s stock effective December ... Northstar,s common stock for depository and book entry ... the Company is now once again fully "DTC ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... FLU OIA test is a high performance ... Influenza A and B with a simple, ... just over 15 minutes. Assay advantages include ... and performance equivalent to 14-day viral culture ...
... The CHLAYMDIA OIA test delivers 100% ... results in 19 minutes. With ... not returning for follow-up, this assay ... which can contribute to detection and ...
... Botox therapy and nerve block procedures, ... needle has a precisely machined Trocar ... an attached 61-cm (24-in) lead wire. ... Single patient use only. A starter ...
Medicine Products: